药物对比
Ertugliflozin vs Rosiglitazone
Ertugliflozin（SGLT2）vs rosiglitazone（TZD），用于2型糖尿病。Ertugliflozin 有黑框警告；rosiglitazone 没有。两者均为口服药，由患者因素决定。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes mellitus seeking to compare oral antidiabetic medications from SGLT2 and thiazolidinedione classes.
结论
Both ertugliflozin and rosiglitazone are effective oral treatments for type 2 diabetes, but the better option depends on individual patient needs.
全部药物对比